Feedback / Questions
VC005 - Jiangsu Vcare Pharma
https://www.prnewswire.com/news-releases/vcare-enters-into-exclusive-partnership-with-huadong-medicine-to-commercialize-its-second-generation-jak1-inhibitor-vc005-tablets-in-china-302530960.html
Aug 15, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next